2,280
Views
14
CrossRef citations to date
0
Altmetric
Research Article

Motor neuron disease mortality rates in U.S. states are associated with well water use

&
Pages 528-534 | Received 10 Feb 2016, Accepted 25 Apr 2016, Published online: 21 Jun 2016

References

  • Salameh JS, Brown RH Jr, Berry D. Amyotrophic lateral sclerosis: review. Semin Neurol. 2015;35:469–76.
  • Armon C. Smoking may be considered an established risk factor for sporadic ALS. Neurology. 2009;17:1693–8.
  • Huisman MHB, de Jong SW, van Doormaal TC, Weinreich SWW, Schelhaas HJ, van der Kooi AJ, et al. Population based epidemiology of amyotrophic lateral sclerosis using capture-recapture methodology. J Neurol Neurosurg Psychiatry. 2011;82:1165–70.
  • O’Reilly ÉJ, Wang H, Weisskopf MG, Fitzergerald KC, Falcon G, McCullough ML, et al. Premorbid body mass index and risk of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14:205–11.
  • Weisskopf MG, O’Reilly EJ, McCullough ML, Calle EE, Thun MJ, Cudkowicz M, et al. Prospective study of military service and mortality from ALS. Neurology. 2005;11:32–7.
  • Seals RM, Kioumourtzoglou M-A, Gredal O, Hansen J, Weisskopf MG. ALS and the military: a population-based study in the Danish registries. Epidemiology. 2016;27:188–93.
  • Ingre C, Roos PM, Piehl F, Kamel F, Fang F. Risk factors for amyotrophic lateral sclerosis. Clin Epidemiol. 2015;7:181–93.
  • Lee SE. Guam Dementia Syndrome revisited in 2011. Curr Opin Neurol. 2011;24:517–24.
  • Neilson S, Robinson I, Clifford Rose F. Ecological correlates of motor neuron disease mortality: a hypothesis concerning an epidemiological association with radon gas and gamma radiation. J Neurol. 1996;243:329–36.
  • Environmental Protection Agency. National Residential Radon Survey. Summary Report.
  • Capello MA, Ferraro A, Mendelsohn AB, Prehn AW. Radon-contaminated drinking water from private wells: an environmental assessment examining a rural Colorado mountain community experience. J Environ Health. 2013;76:18–24.
  • http://wonder.cdc.gov/ucd-icd10.html. Accessed January 31, 2016.
  • Armon C. Amyotrophic Lateral Sclerosis. In: Nelson LM, Tanner CM, van den Eeden SK, McGuire VM, editors. Neuroepidemiology: Oxford, UK Oxford University Press: From Principles to Practice; 2004. pp 162–87.
  • Marin B, Couratier P, Preux P-M, Logroscino G. Can mortality data be used to estimate amyotrophic lateral sclerosis incidence? Neuroepidemiol. 2011;36:29–38.
  • Schwartz GG, Klug MG. Incidence rates of chronic lymphocytic leukemia in US states are associated with residential radon levels. Future Oncol. 2016;12:165–74.
  • Kenny JF, Barber NL, Hutson SS, Linsey KS, Lovelace JK, Maupin MA. Estimated use of water in the United States in 2005. Circular 1344, U.S. Department of the Interior, U.S. Geological Survey, Reston, VA; 2009.
  • Hutson SS. Guidelines for preparation of state water use estimates for 2005. U.S. Department of the Interior, U.S. Geological Survey. Available at: http://pubs.usgs.gov/tm/2007/tm4e1/pdf/tm4-e1.pdf. Accessed February 10, 2015.
  • https://www.census.gov/. Accessed January 29, 2016.
  • http://www.cdc.gov/brfss/. Accessed January 29, 2016.
  • Noonan CW, White MC, Thurman D, Wong L-Y. Temporal and geographic variation in United States motor neuron disease mortality, 1969–1998. Neurology. 2005;64:1215–21.
  • Rechtman L, Jordan H, Wagner L, Horton DK, Kaye W. Racial and ethnic differences among amyotrophic lateral sclerosis cases in the United States. Amyotroph Lateral Scler Frontal Degener. 2015;16:65–71.
  • Kurtzke JF. Epidemiology of amyotrophic lateral sclerosis. Adv Neurol. 1982;36:281–302.
  • Bharucha NE, Schoenberg BS, Raven RH, Pickle LW, Byar DP, Mason TJ. Geographic distribution of motor neuron disease and correlation with possible etiologic factors. Neurology. 1983;33:911–5.
  • Sejvar JJ, Holman RC, Bresee JS, Kochanek KD, Schonberger LB. Amyotrophic lateral slerosis mortality in the United States, 1979–2001. Neuroepidemiol. 2005;25:144–52.
  • Hart LG, Larson EH, Lishner DM. Rural definitions for health policy and research. Am J Public Health. 2005;95:1149–55.
  • Belabsis L, Bellou V, Evangelou E. Environmental risk factors and amyotrophic lateral sclerosis: a umbrella review and critical assessment of current evidence from systematic reviews and meta-analyses of observational studies. Neuroepidemiol. 2016:46:96–105.
  • Alonso A, Logroscino G, Hernán MA. Smoking and the risk of amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2010;81:1249–52.
  • Vincenti M, Bonvicini F, Rothman KJ, Vescovi L, Wang F. The relation between amyotrophic lateral sclerosis and inorganic selenium in drinking water: a population based case-control study. Environ Health. 2010;9:77.
  • Poloni M, Micheli A, Facchetti D, Mai R, Ceriani F, Cattalini C. Conjugal amyotrophic lateral sclerosis: toxic clustering or chance? Int J Neurol Sci. 1987;18:109–12.
  • Malek AM, Burchowsky A, Bowser R, Herman-Patterson T, Lacomis D, Rana S, et al. Environmental and occupational risk factors for amyotrophic lateral sclerosis: a case-control study. Neurodegener Dis. 2014;14:31–8.
  • Das K, Nag C, Ghosh M. Familial, environmental, and occupational risk factors in the development of amyotrophic lateral sclerosis. N Am J Med Sci. 2012;4:350–5.
  • Ludolph AC, Knirsch U. Problems and pitfalls in the diagnosis of ALS. Neurol Sci. 1999;165 (Suppl): S14–20.
  • Stickler DE, Royer JA, Hardin JW. Accuracy and usefulness of ICD-10 death certificate coding for the identification of patients with ALS: results from the South Carolina ALS Surveillance Pilot Project. Amyotroph Lateral Scler. 2012;13:69–73.
  • Kiourmourtzoglou MA, Seals RM, Himmerslev L, Gredal O, Hansen J, Weisskopf MG. Comparison of diagnoses of amyotrophic lateral sclerosis by use of death certificates and hospital discharge data in the Danish population. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16:224–9.
  • Cronin S, Hardiman O, Traymor BJ. Ethnic variation in the incidence of ALS. A systematic review. Neurology. 2007;68:1002–7.
  • Hixon L, Hepler BB, Kim MO. The White population: 2010. 2010 Census Briefs. September 2011.
  • Ennis SR, Rios-Vargas M, Albert NG. The Hispanic population: 2010. 2010 Census Briefs, May 2011.
  • Yoder J, Roberts V, Craun FG, Hill V, Hicks LA, Alexander NT, et al. Surveillance for waterborne disease and outbreaks associated with drinking water and water not intended for drinking – United States 2005–2006. MMWR Surveill Summ. 2008;57:39–62.
  • Steinert M, Hentschel U, Hacker J. Legionella pneumophila: an aquatic microbe goes astray. FEMS Micrbiol Rev. 2002;26:149–62.
  • Falkinham JO III, Hilborn ED, Arduino MJ, Pruden A, Edwards MA. Epidemiology and ecology of opportunistic plumbing pathogens: Legionella pneumophila, Mycobacterium avium, and Pseudomonas aeruginosa. Environ Health Perspect. 2015;123:749–58.
  • Strauss WL, Plouffe JF, File JM Jr, Lipman HB, Hackman BH, Salstrom SJ,. Ohio Legionnaires Disease Group. Risk factors for domestic acquisition of Legionnaires’ disease. Arch Intern Med. 1996;156:1685–92.
  • Stout JE, Yu VL, Muraca P, Joly J, Troup N, Tompkins LS. Potable water as a cause of sporadic cases of community-acquired Legionnaires’ disease. N Eng J Med. 1992;326:15–155.
  • Gregory DW, Schaffner W, Alford RH, Kaiser AB, McGee ZA. Sporadic cases of Legionnaires’ disease: the expanding clinical spectrum. Ann Intern Med. 1979;90:518–21.
  • Baker PCH, Price TRP, Allen CD. Brain stem and cerebellar dysfunction with Legionnaires’ disease. J Neurol Neurosurg Psychiat. 1981;44:1054–6.
  • Basani S, Ahmed M, Habte-Gabr E. Legionnaires’ disease with facial nerve palsy. Case Rep Medicine. 2011;10:1–4.
  • Vigneri S, Spadaro S, Faronelli I, Ragazzi R, Bolta CA, Capone JG, et al. Acute respiratory failure onset in a patient with Guillain-Barré syndrome after Legionella-associated pneumonia: a case report. J Clin Neuromusc Dis. 2014;16:74–8.
  • Canpolat M, Kumandas S, Yikilmaz A, Gumus H, Koseoglu E, Poyrazoğlu HG, et al. Transverse myelitis and acute motor sensory axonal neuropathy due to Legionella pneumophila: a case report. Ped International. 2013;55:778–82.
  • Vigneri S, Spadaro S, Faronelli I, Ragazzi R, Bolta CA, Capone JG, et al. Acute respiratory failure onset in a patient with Guillain-Barré syndrome after Legionella-associated pneumonia: a case report. J Clin Neuromusc Dis. 2014;16:74–8.
  • Sakamoto R, Ohno A, Nakahara T, Satomura K, Iwanaga S, Saito M, et al. A patient with Legionnaires’ disease transferred after a traffic accident. Br Med J case report 2009;doi:10.1136/bcr.09.2008.0893.c.
  • Shelburne SA, Kielhofner MA, Tiwary PS. Cerebeller involvement in legionellosis. South Med J. 2004;97:61–4.
  • Calza L, Briganti E, Casolari S, Manfredi R, d’Orsi G, Chiodo F, et al. Severe peripheral neuropathy with arreflexia and flaccid quadriplegia complicating Legionnaires’ disease in an adult patient. Infect Dis Clin Pract. 2004;12:110–3.
  • Harris LF. Legionnaires’ disease associated with acute encephalomyelitis. Arch Neurol. 1981;38:462–3.
  • Lattimer GL, Rhodes LV III, Salventi JS, Galgon JP, Stonebraker V, Boley S, et al. The Philadelphia epidemic of Legionnaire’s Disease. Clinical, pulmonary, and serologic findings two years later. Ann Intern Med. 1970;90:522–36.
  • Naot Y, Brown A, Elder EM, Shonnard J. IgM and IgG antibody response in two immunosuppressed patients with Legionnaires’ disease. Evidence of reactivation of latent infection. Am J Med. 1982;73:791–4.
  • Gläser S, Weitzel T, Schiller R, Suttorp N, Lück PC. Persistent culture-positive Legionella infection in an immunocompetent adult. Clin Infect Dis. 2995;41:765–6.
  • Nagelkerke NJD, Boshuizen HC, de Melker HE, Schellekens JFP, Peeters MF, Conyn-van Spaendonck M. Estimating the incidence of subclinical infections with Legionella pneumonia using data augmentation: analysis of an outbreak in the Netherlands. Stat Med. 2003;22:3713–24.
  • Warner CL, Fayad PB, Heffner RR Jr. Legionella myositis. Neurology. 1991;41:750–2.
  • Monforte R, Marco F, Estruch R, Campo E. Multiple organ involvement by Legionella pneumophila in a fatal case of Legionnaires’ disease. J Infect Dis. 1989;159:809.
  • Perpoint T, Jamilloux Y, Descloux E, Ferry T, Chidiac C, Lina G, et al. PCR-confirmed Legionella non-pneumophila meningoencephalitis. Med Maladies Infect. 2013;43:32–4.
  • Charles M, Johnson E, Macyk-Davey A, Henry M, Nilsson J-E, Miedzinski L, et al. Legionella micdadei brain abscess. J Clin Microbiol. 2013;51:701–2.
  • Weir AI, Bone I, Kennedy DH. Neurological involvement in legionellosis. J Neurol Neurosurg Psychiatry. 1982;45:603–8.
  • Wong KH, Moss CW, Hochstein DH, Arko RJ, Schalla WO. ‘Endotoxicity’ of the Legionnaires’ disease bacterium. Ann Intern Med. 1979;90:624–7.
  • European Center for Disease Prevention and Control. Legionnaires’ disease in Europe 2012. Stockholm:ECDC; 2014.
  • Beard JD, Kamel F. Military service, deployments, and exposures in relation to amyotrophic lateral sclerosis. Epi Rev. 2015;37:55–70.
  • Amundson DE, Weiss PJ. Pneumonia in military recruits. Mil Med. 1994;159:629–31.
  • McDonough EA, Metzgar D, Hansen CJ, Myers CA, Russell KL. A cluster of Legionella-acquired pneumonia cases in a population of military recruits. J Clin Microbiol. 2007;45:20127–75.
  • Broome CV, Goings SA, Thacker SB, Vogt RL, Beaty HN, Fraser DW. The Vermont epidemic of Legionnaires’ disease. Ann Intern Med. 1979;90:573–7.
  • Klaucke DN, Vogt RL, LaRue D, Witherell LE, Orciari LA, Spitalny KC, et al. Legionnaires’ disease: the epidemiology of two outbreaks in Burlington, Vermont, 1980. Am J Epidemiol. 1984;119:382–91.
  • Atlas RM. Legionella: from environmental habitats to disease pathology, detection and control. Env Microbiol. 1999;1:283–93.
  • Costa J, da Costa MS, Veríssimo A. Colonization of a therapeutic spa with Legionella spp: a public health issue. Res Microbiol. 2010;161:18–25.
  • Pedro-Botet ML, Yu VL. Treatment strategies for Legionella infection. Expert Opin Pharmacother. 2009;10:1109–21.
  • Savitz DA. A niche for ecologic studies in environmental epidemiology. Epidemiology. 2012; 23:53–4.